Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
Característiques principals
The Call has the following topics:
  • Topic 1: Vaccine development Phase I, II, and III
  • Topic 2: Manufacturing capability
  • Topic 3: Stability of vaccines during transport and storage
  • Topic 4: Deployment and compliance of vaccination regimens
  • Topic 5: Rapid diagnostic tests
    • Característiques principals
    This Call is being run in a single stage, fast-track procedure.
    Applicant Consortia should prepare a Full Proposal directly based on the proposal template.
    Full Proposals must be submitted via the IMI electronic submission tool SOFIA (https://sofia.imi.europa.eu/Pages/Login.aspx?ReturnUrl=%2fPages%2fDefault.aspx).<
    Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    • Carol Barnwell, cbarnwell@imim.es. Ext.: 1670
    • Marta López, mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    http://www.imi.europa.eu/content/imi-2-call-2-0
    Dotació
    IMI JU collaborative projects are implemented through a co-financing scheme. The IMI JU grants financial support to the eligible entities, while the other entities (including the EFPIA companies) participate in the project with their own resources.
    The EU contribution is:
  • Topic 1: 70-100 million EUR
  • Topic 2: 10-20 million EUR
  • Topic 3: 2 million EUR
  • Topic 4: 25 million EUR
  • Topic 5: 7.5 million EUR

    • Arxius

    Arxiu
    Call text